(Hypertension. 2000;36:471.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Epidemiology (J.S.P., K.M.R.), University of North Carolina, Chapel Hill; the Division of Preventive Medicine (A.O.), University of Alabama, Birmingham; Cardiovascular Genetics (S.C.H.), University of Utah, Salt Lake City; the Division of Epidemiology (L.D.A.), University of Minnesota, Minneapolis; the Section of Preventive Medicine and Epidemiology (L.D.), Boston University, Boston, Mass; and the Division of Biostatistics (M.A.P., D.C.R.), Washington University School of Medicine, St. Louis, Mo.
Correspondence to Dr James S. Pankow, Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Bank of America Center, Suite 306, 137 E Franklin St, Chapel Hill, NC 27514. E-mail jim pankow{at}unc.edupankow@unc.edu
| Abstract |
|---|
|
|
|---|
140 mm Hg, diastolic blood pressure
90 mm Hg, or on antihypertensive medications) with diagnosis
before age 60. Blood pressure and pulse were measured by an
oscillometric method after a 5-minute rest in a supine position and
again immediately on standing. The genome scan included a total of 387
autosomal short-tandem-repeat polymorphisms typed by the National
Heart, Lung, and Blood Institute Mammalian Genotyping Service at
Marshfield. We used multipoint variance-components linkage
analysis to identify possible quantitative trait loci
influencing postural change phenotypes after adjusting for sex,
age, and use of antihypertensive medications. There was suggestive
evidence for linkage on chromosome 18q for the postural
systolic blood pressure response (maximum logarithm of the odds
score=2.6 at 80 centiMorgans). We also observed a maximum logarithm of
the odds score of 1.9 for the systolic blood pressure response
and 1.7 for the diastolic blood pressure response on
chromosome 6p. The marker that demonstrated the strongest evidence for
linkage for the systolic blood pressure response (D18S858) lies
within 20 centiMorgans of a marker previously linked to rare familial
orthostatic hypotensive syndrome. Our findings indicate
that there may be 1 or more genes on chromosome 18q that regulate
systolic blood pressure during the
physiological recovery period after a postural
stressor.
Key Words: posture blood pressure heart rate hypertension linkage chromosome mapping
| Introduction |
|---|
|
|
|---|
Family and twin studies suggest that blood pressure and heart rate responses to laboratory stressors such as a mental arithmetic or cold pressor test are partly under genetic control.6 7 8 9 10 11 12 By contrast, fewer studies have evaluated familial patterns of blood pressure or heart rate responses to postural stressors. A relatively severe form of orthostatic hypotension with an autosomal dominant mode of transmission has been described in 4 families.13 Recently, a genome-wide scan in 2 of these families found significant evidence for linkage of this hypotensive trait in a region on chromosome 18q.14
Unlike most other laboratory stressors designed to evaluate cardiovascular reactivity, a change in body position from supine to standing is a daily challenge that can lead to either a decrease or an increase in blood pressure.15 Because the physiological mechanisms leading to an increase in blood pressure on standing probably differ from those leading to a decrease in blood pressure on standing, genetic influences on the blood pressure response to postural stressors may be heterogeneous. In the present study, we report the results of a genome-wide scan in hypertensive sibling-pairs for quantitative trait loci influencing the systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse responses to a change from a supine to a standing position.
| Methods |
|---|
|
|
|---|
For the purposes of recruitment into HyperGEN as a member of a
hypertensive sibship, eligibility was based on (1) the clinical
diagnosis or treatment of hypertension before age 60 (excluding
hypertension only during pregnancy), (2) current blood pressure levels
140 mm Hg systolic or 90 mm Hg
diastolic, (3) current use of recognized antihypertensive
medications, or (4) the historical (but not current) treatment for
hypertension with prescribed medications for at least 1 year during the
past 5 years, all of which occurred before age 60. Individuals with a
lifetime history of kidney failure were excluded. To optimize
statistical power, all hypertensive full siblings were recruited from
each eligible sibship. A random sample of white subjects and their
spouses was also recruited from the study communities (n=472).
All participants completed a detailed clinic examination with protocols standardized across centers. Participants were asked to avoid caffeine, eating, and heavy physical activity for 12 hours before the examination. The study was approved by an institutional review committee at each center, and subjects gave informed consent. Procedures followed were in accordance with institutional guidelines.
Blood Pressure and Pulse Measurements
To assess hemodynamic responses to a postural
challenge, SBP, DBP, and pulse rate were measured on the dominant arm
with a DINAMAP 1846-SX/P oscillometric device. All measurements were
directly downloaded to a personal computer. According to arm
circumference, measurements were taken with 1 of 5 standardized cuffs:
child, small adult, adult, large adult, and thigh. One supine
measurement was taken after a 5-minute period of rest. Participants
were then instructed to rise as quickly as possible, and standing
measurements were taken immediately and again 2 minutes after standing.
Between 15 and 35 seconds were required to complete each blood pressure
and pulse determination, depending on the heart rate.
Other Measurements
Current use of prescription medications was ascertained, and
medication codes were assigned by a computerized protocol administered
by trained and certified staff. Codes were collapsed into therapeutic
categories (Medispan) by the Data Coordinating Center. The examination
also included questionnaires to determine physical activity, history of
cigarette smoking, alcohol intake, and reproductive history. Blood
samples were collected to determine fasting lipids and lipoproteins and
serum chemistries.
Height, weight, and waist girth were measured by a trained and certified technician on shoeless participants wearing scrub suits and nonconstricting underwear, by using a standardized protocol and calibrated instruments. All measurements were recorded to the nearest unit and rounded down, when necessary. Standing height was measured on a fixed stadiometer with the participants head in the Frankfort horizontal plane and recorded to the nearest centimeter. Weight was measured on a balance scale and recorded to the nearest pound. We used these measures to compute body mass index (BMI, in kg/m2). Waist circumference was measured at the umbilicus and recorded to the nearest centimeter at the point of relaxed end-exhalation. Serum insulin was measured by an immunoenzymatic method with the Beckman/Sanofi Access analyzer (Beckman). HDL quantification was performed with the standard cholesterol method after precipitation of non-HDL cholesterol with magnesium/dextran.18
Genotyping
Genotype data on 387 autosomal short-tandem-repeat
polymorphisms were provided by the NHLBI Mammalian Genotyping
Service at Marshfield. The results presented herein are based
on marker data from all participants who have been genotyped to
date, representing approximately one half of the white
sibships. Because there were fewer African-American sib-pairs enrolled
in HyperGEN and statistical power is therefore more limited, genome
scan results for these postural blood pressure and pulse
phenotypes will not be presented until all
African-American participants have been genotyped.
Statistical Analysis
Because maximal hemodynamic responses have been
observed within the first minute after a postural
stressor,19 our primary analysis focused on the
initial response of blood pressure and pulse to a change in posture
(ie, a change in blood pressure and pulse measured immediately on
rising from a supine to a standing position). We analyzed 3
postural change phenotypes that reflected the difference
between standing and supine measures: (1) change in SBP; (2) change in
DBP; and (3) change in pulse. We applied a natural-log transformation
to normalize the distribution of
pulse, which was positively skewed.
Extreme outliers were deleted (>4 SDs and >1 SD from the nearest
point). Sex-specific regression models were developed in participants
from the random sample to assess the effects of age (up to cubic terms)
and self-reported use of prescription antihypertensive medications in
the past 4 weeks. Phenotypes for members of hypertensive
sibships were then adjusted by using regression coefficients from these
models, and the standardized residuals for each of the
phenotypes were used in linkage analysis.
Reported family relationships were compared for consistency with the marker genotype data by using the program ASPEX20 and corrected, as necessary. Any remaining genotype inconsistencies within pedigrees were "zeroed out" (set to missing), marker by marker, by using a fully automated SAS macro that repeatedly called the program MAPMAKER/SIBS.21
We conducted multipoint variance-components linkage analysis by using SEGPATH.22 The expected genetic covariance between relatives was modeled as a function of the identity-by-descent at a given test locus and the kinship coefficient. Heritability (h2) was partitioned into a component attributable to a latent trait locus (hg2) and residual heritability (hr2) attributable to other trait genes and/or other sources of familial resemblance. The null hypothesis that there was no effect of the test locus on the trait heritability (hg2=0) was evaluated by a likelihood-ratio test. MAPMAKER/SIBS21 was used to estimate the allele-sharing proportions among siblings. Population marker allele frequencies were estimated from the random sample. When simulated data from Genetic Analysis Workshop 10 were analyzed under the same set of assumptions,22 SEGPATH and SOLAR23 gave identical results, thus making the variance-components implementations in the 2 programs very comparable.
| Results |
|---|
|
|
|---|
|
The distributions of
SBP,
DBP, and log
pulse were
approximately normally distributed after adjusting for sex, age, and
antihypertensive medications. In participants from the random sample,
SBP and
DBP were moderately correlated (r=0.41,
P<0.001). By contrast, log
pulse was only weakly
correlated with either
SBP (r=-0.07, P=0.14)
or
DBP (r=0.13, P=0.01). Changes in blood
pressure and pulse computed with the first (immediate) standing
measurement were moderately correlated with changes computed with the
second (2-minute) standing measurement (for
SBP, r=0.58,
P<0.001; for
DBP, r=0.61,
P<0.001; and for log
pulse, r=0.48,
P<0.001).
Generalized heritability estimates (±SE) obtained from
SEGPATH were 0.36 (±0.06) for
SBP, 0.25 (±0.05) for
DBP, and 0.40 (±0.07) for log
pulse. Map locations and marker
names for all locations yielding a maximum log-of-the-odds (LOD) score
1.5 are provided in Table 2. Multipoint
LOD scores for
SBP are plotted by map position in the
Figure. The genome-wide scan for
SBP
indicated suggestive linkage to a broad region on chromosome 18q, with
a maximum LOD of 2.6 at marker ATA23G05 (D18S858),
80 cM from the p
terminus. Other regions of potential interest include a LOD of 1.9 for
SBP and 1.7 for
DBP associated with marker GATA163B10 on
chromosome 6p. There were no regions with a LOD
1.5 for log
pulse.
|
|
We evaluated other possible predictors of postural blood pressure or
pulse responses, including educational attainment, BMI, waist
circumference, fasting insulin and glucose, prevalent diabetes, LDL and
HDL cholesterol levels, sitting SBP and DBP, and smoking
status. However, other than age and use of prescription
antihypertensive medications in the past 4 weeks, no other
variables were statistically significantly associated
(P<0.05) with
SBP. Further adjustments for other
variables significantly associated with
DBP (waist
circumference, fasting insulin) and log
pulse (BMI, HDL
cholesterol) had little impact on the maximum LOD scores
described above. We also found evidence of heritability (0.31±0.05)
for
SBP computed with the 2-minute rather than the immediate
standing blood pressure measurement but failed to identify a
significant peak on chromosome 18q (maximum LOD=0.6).
| Discussion |
|---|
|
|
|---|
SBP in a broad region on
chromosome 18q (maximum LOD=2.6 at 80 cM). By contrast, there was no
evidence for linkage of
DBP or
pulse in this chromosomal region.
Although the maximum LOD score for
SBP on chromosome 18q did not
reach the standard for significant linkage as proposed by Lander and
Kruglyak,24 this finding is important because it overlaps
with a region on 18q recently linked to familial
orthostatic hypotensive syndrome,14 a related
postural blood pressure trait. The marker with the highest LOD score
for
SBP in our study (D18S858) lies within 20 cM of the marker with
the highest LOD score for orthostatic hypotensive syndrome
in the earlier study by DeStefano et al14 (D18S1367,
LOD=3.9). DeStefano et al14 investigated a small group of extended families whose members suffered from frequent episodes of dizziness, syncope, headaches, and leg edema on rising from a supine position. Orthostatic hypotension was defined as a drop in SBP by >18 mm Hg and a rise in pulse on standing. Because the familial form of this disorder is thought to be rare, the locus on 18q detected by DeStefano et al may be of little or no importance in regulating postural blood pressure for most individuals or families in the population. On the other hand, identifying and characterizing genes involved in rare familial forms of hypertensive or hypotensive disorders may provide insights into the general physiology of blood pressure control.25 26 In a population-based study of Mexican-Americans, Atwood et al27 recently found suggestive linkage (maximum LOD=2.1) of hypertension to marker D18S844, which is within 30 cM of the linkage found in our study and within 10 cM of the linkage reported by DeStefano et al. Our findings and those of Atwood et al suggest that this region of chromosome 18q may contain 1 or more genes with much broader significance for blood pressure regulation. It is also possible that we have localized a gene that primarily influences normal hemodynamic adjustments to the upright posture because the blood pressure responses of the vast majority of participants included in our analysis would not be characterized as "abnormal" by conventional definitions.28
Several factors limit the generalizability of our study and suggest
that future studies may have some difficulty replicating our findings,
unless comparable study designs, protocols, and instruments are used.
First, we found suggestive evidence for linkage only when
SBP was
determined with measurements taken immediately on standing, but not
when the blood pressure response was determined with measurements taken
2 minutes after standing. This finding might indicate that genetic
factors that operate early in the physiological
recovery period after a postural stressor differ from those that
influence compensatory changes in blood pressure at later stages of
recovery. The relative impact of genetic factors on SBP levels may be
greatest immediately after standing, although in our study heritability
estimates for
SBP were of similar magnitude when computed with
either the immediate or the 2-minute standing measurements. Second,
although participants in our study were not selected on the basis of
orthostatic hypotension status, the pattern of blood
pressure and pulse responses to a postural challenge may be atypical,
because only hypertensive sibships were selected for our study. For
example, the mean (SD) of
SBP was -2.8 (15.1) mm Hg in
hypertensive sibships compared with +0.4 (11.6) mm Hg in the
random sample. In addition, the percentage of participants with a
decrease in SBP of at least 20 mm Hg on standing was also higher
in hypertensive sibships (11.7%) compared with the random sample
(4.5%), possibly because individuals with hypertension and those using
antihypertensive medications are more likely to have postural
hypotension.1 We cannot determine from these data whether
genetic factors influencing postural blood pressure and heart rate
responses are likely to be similar in hypertensives and
nonhypertensives.
Measurement error likely reduced statistical power to detect quantitative trait loci for the blood pressure and pulse phenotypes in our study. Blood pressure and pulse exhibit substantial intraindividual variability, some of which can be attributed to measurement error.29 Although the DINAMAP device has been found to have high repeatability,30 measurement error is compounded when change scores are computed, because each score is based on 2 blood pressure or pulse determinations, each measured with error. For example, a study of patients >60 years old with isolated systolic hypertension found lower reproducibility for orthostatic changes in SBP compared with the reproducibility of either supine or standing SBP measured by conventional sphygmomanometry.31 In another reproducibility study in elderly patients, intraclass correlation coefficients were somewhat higher for postural SBP changes (0.72) and pulse changes (0.69) compared with DBP changes (0.50).32
In addition to possible measurement error introduced by instrumentation and study protocol, use of prescription antihypertensive medications may have also obscured normal physiological responses to the postural stressor in some individuals. Our ability to adequately account for possible medication effects is limited because >90% of participants in our study were current users of antihypertensive medications. Although participants were fasting at the time of arrival at the clinic, they were offered a snack before the postural blood pressure determinations, which may have triggered postprandial decreases in blood pressure in some individuals.33 Some of the participants may have also had other common causes of postural hypotension, such as anemia, hypokalemia, or valvular disease.
In conclusion, our genome-wide scan found a possible locus on chromosome 18q influencing the SBP response to a postural challenge in white hypertensive siblings. DeStefano et al14 had previously found significant evidence for linkage of a rare familial form of orthostatic hypotension in this same region. Our analysis suggests that there may be 1 or more genes in this region regulating postural SBP responses in hypertensive individuals not selected on the basis of orthostatic hypotension status. Because complex traits such as sitting blood pressure and postural blood pressure change are likely to be influenced by multiple genes with modest (polygenic) effects, it will be difficult for linkage studies such as our own to produce convincing levels of evidence.34 Therefore, some of the less significant findings reported herein may also be of interest.
| Acknowledgments |
|---|
Received May 30, 2000; first decision June 30, 2000; accepted August 14, 2000.
| References |
|---|
|
|
|---|
-subunit: genetic heterogeneity of Liddle syndrome.
Nat Genet. 1995;11:7682.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
C. Moreno, M. L. Kaldunski, T. Wang, R. J. Roman, A. S. Greene, J. Lazar, H. J. Jacob, and A. W. Cowley Jr. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat Physiol Genomics, October 19, 2007; 31(2): 228 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Guzman, B. Cormand, M. Ribases, D. Gonzalez-Nunez, A. Botey, and E. Poch Implication of Chromosome 18 in Hypertension by Sibling Pair and Association Analyses: Putative Involvement of the RKHD2 Gene Hypertension, November 1, 2006; 48(5): 883 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Bielinski, A. I. Lynch, M. B. Miller, A. Weder, R. Cooper, A. Oberman, Y.-D. I. Chen, S. T. Turner, M. Fornage, M. Province, et al. Genome-Wide Linkage Analysis for Loci Affecting Pulse Pressure: The Family Blood Pressure Program Hypertension, December 1, 2005; 46(6): 1286 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Staub and F. Verrey Impact of Nedd4 Proteins and Serum and Glucocorticoid-Induced Kinases on Epithelial Na+ Transport in the Distal Nephron J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3167 - 3174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Russo, E. Melista, J. Cui, A. L. DeStefano, G. L. Bakris, A. J. Manolis, H. Gavras, and C. T. Baldwin Association of NEDD4L Ubiquitin Ligase With Essential Hypertension Hypertension, September 1, 2005; 46(3): 488 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fouladkou, R. Alikhani-Koopaei, B. Vogt, S. Y. Flores, L. Malbert-Colas, M.-C. Lecomte, J. Loffing, F. J. Frey, B. M. Frey, and O. Staub A naturally occurring human Nedd4-2 variant displays impaired ENaC regulation in Xenopus laevis oocytes Am J Physiol Renal Physiol, September 1, 2004; 287(3): F550 - F561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Mein, M. J. Caulfield, R. J. Dobson, and P. B. Munroe Genetics of essential hypertension Hum. Mol. Genet., April 1, 2004; 13(90001): R169 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. North, K. M. Rose, I. B. Borecki, A. Oberman, S. C. Hunt, M. B. Miller, J. Blangero, L. Almasy, and J. S. Pankow Evidence for a Gene on Chromosome 13 Influencing Postural Systolic Blood Pressure Change and Body Mass Index Hypertension, April 1, 2004; 43(4): 780 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Harrap, J. S. Cui, Z. Y. H. Wong, and J. L. Hopper Familial and Genomic Analyses of Postural Changes in Systolic and Diastolic Blood Pressure Hypertension, March 1, 2004; 43(3): 586 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gong, H. Zhang, H. Schulz, Y.-A. Lee, K. Sun, S. Bahring, F. C. Luft, P. Nurnberg, A. Reis, K. Rohde, et al. Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p Hum. Mol. Genet., June 1, 2003; 12(11): 1273 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Cooper, A. Luke, X. Zhu, D. Kan, A. Adeyemo, C. Rorimi, N. Bouzekri, and R. Ward Genome Scan Among Nigerians Linking Blood Pressure to Chromosomes 2, 3, and 19 Hypertension, November 1, 2002; 40(5): 629 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kamynina and O. Staub Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na+ transport Am J Physiol Renal Physiol, September 1, 2002; 283(3): F377 - F387. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hunt, R. C. Ellison, L. D. Atwood, J. S. Pankow, M. A. Province, and M. F. Leppert Genome Scans for Blood Pressure and Hypertension: The National Heart, Lung, and Blood Institute Family Heart Study Hypertension, July 1, 2002; 40(1): 1 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kristjansson, A. Manolescu, A. Kristinsson, T. Hardarson, H. Knudsen, S. Ingason, G. Thorleifsson, M. L. Frigge, A. Kong, J. R. Gulcher, et al. Linkage of Essential Hypertension to Chromosome 18q Hypertension, June 1, 2002; 39(6): 1044 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Doris Hypertension Genetics, Single Nucleotide Polymorphisms, and the Common Disease:Common Variant Hypothesis Hypertension, February 1, 2002; 39(2): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ranade, K.-D. Wu, C.-M. Hwu, C.-T. Ting, D. Pei, R. Pesich, J. Hebert, Y.-D. I. Chen, R. Pratt, R. Olshen, et al. Genetic variation in the human urea transporter-2 is associated with variation in blood pressure Hum. Mol. Genet., September 1, 2001; 10(19): 2157 - 2164. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rankinen, P. An, T. Rice, G. Sun, Y. C. Chagnon, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, D. C. Rao, et al. Genomic Scan for Exercise Blood Pressure in the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study Hypertension, July 1, 2001; 38(1): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft and A. Busjahn Peaks and Valleys Hypertension, July 1, 2001; 38(1): 38 - 40. [Full Text] [PDF] |
||||
![]() |
L. D. Atwood, P. B. Samollow, J. E. Hixson, M. P. Stern, and J. W. MacCluer Genome-Wide Linkage Analysis of Pulse Pressure in Mexican Americans Hypertension, February 1, 2001; 37(2): 425 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Re On the Sequencing of the Human Genome Hypertension, October 1, 2000; 36(4): 469 - 470. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||